| Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016 H Jalal, JM Buchanich, MS Roberts, LC Balmert, K Zhang, DS Burke Science 361 (6408), eaau1184, 2018 | 647 | 2018 |
| Microsimulation modeling for health decision sciences using R: a tutorial EM Krijkamp, F Alarid-Escudero, EA Enns, HJ Jalal, MGM Hunink, ... Medical Decision Making 38 (3), 400-422, 2018 | 157 | 2018 |
| Network meta-analysis of margin threshold for women with ductal carcinoma in situ SY Wang, H Chu, T Shamliyan, H Jalal, KM Kuntz, RL Kane, BA Virnig Journal of the National Cancer Institute 104 (7), 507-516, 2012 | 151 | 2012 |
| An overview of R in health decision sciences H Jalal, P Pechlivanoglou, E Krijkamp, F Alarid-Escudero, E Enns, ... Medical decision making 37 (7), 735-746, 2017 | 111 | 2017 |
| Forecasting trends in disability in a super-aging society: adapting the future elderly model to Japan BK Chen, H Jalal, H Hashimoto, S Suen, K Eggleston, M Hurley, ... The Journal of the Economics of Ageing 8, 42-51, 2016 | 97 | 2016 |
| Linear Regression Metamodeling as a Tool to Summarize and Present Simulation Model Results KMK Hawre Jalal, Bryan Dowd, François Sainfort Medical Decision Making, 2013 | 74 | 2013 |
| Computing expected value of partial sample information from probabilistic sensitivity analysis using linear regression metamodeling H Jalal, JD Goldhaber-Fiebert, KM Kuntz Medical Decision Making 35 (5), 584-595, 2015 | 60 | 2015 |
| A Gaussian approximation approach for value of information analysis H Jalal, F Alarid-Escudero Medical Decision Making 38 (2), 174-188, 2018 | 59 | 2018 |
| Carfentanil and the rise and fall of overdose deaths in the United States H Jalal, DS Burke Addiction 116 (6), 1593-1599, 2021 | 56 | 2021 |
| A need for change! A coding framework for improving transparency in decision modeling F Alarid-Escudero, EM Krijkamp, P Pechlivanoglou, H Jalal, SYZ Kao, ... Pharmacoeconomics 37 (11), 1329-1339, 2019 | 54 | 2019 |
| Age and generational patterns of overdose death risk from opioids and other drugs H Jalal, JM Buchanich, DR Sinclair, MS Roberts, DS Burke Nature medicine 26 (5), 699-704, 2020 | 49 | 2020 |
| Computing PROPr utility scores for PROMIS® profile instruments B Dewitt, H Jalal, J Hanmer Value in Health 23 (3), 370-378, 2020 | 46 | 2020 |
| Calculating the expected value of sample information in practice: considerations from 3 case studies A Heath, N Kunst, C Jackson, M Strong, F Alarid-Escudero, ... Medical Decision Making 40 (3), 314-326, 2020 | 45 | 2020 |
| Computing the expected value of sample information efficiently: practical guidance and recommendations for four model-based methods N Kunst, ECF Wilson, D Glynn, F Alarid-Escudero, G Baio, A Brennan, ... Value in Health 23 (6), 734-742, 2020 | 40 | 2020 |
| Cost‐effectiveness of triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis H Jalal, JR O'Dell, SL Bridges Jr, S Cofield, JR Curtis, TR Mikuls, ... Arthritis care & research 68 (12), 1751-1757, 2016 | 40 | 2016 |
| “Time traveling is just too dangerous” but some methods are worth revisiting: the advantages of expected loss curves over cost-effectiveness acceptability curves and frontier F Alarid-Escudero, EA Enns, KM Kuntz, TL Michaud, H Jalal Value in Health 22 (5), 611-618, 2019 | 37 | 2019 |
| Data needs in opioid systems modeling: challenges and future directions MS Jalali, E Ewing, CB Bannister, L Glos, S Eggers, TY Lim, ... American journal of preventive medicine 60 (2), e95-e105, 2021 | 31 | 2021 |
| Some health states are better than others: using health state rank order to improve probabilistic analyses JD Goldhaber-Fiebert, HJ Jalal Medical Decision Making 36 (8), 927-940, 2016 | 29 | 2016 |
| Estimating the impact of low influenza activity in 2020 on population immunity and future influenza seasons in the United States K Lee, H Jalal, JM Raviotta, MG Krauland, RK Zimmerman, DS Burke, ... Open Forum Infectious Diseases 9 (1), ofab607, 2022 | 20 | 2022 |
| An introductory tutorial on cohort state-transition models in R using a cost-effectiveness analysis example F Alarid-Escudero, E Krijkamp, EA Enns, A Yang, MGM Hunink, ... Medical Decision Making 43 (1), 3-20, 2023 | 19 | 2023 |
Don BurkeProfessor of Epidemiology, University of PittsburghVerified email at pitt.edu
